Pulmonx Corp (LUNG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,162 | 63,570 | 63,721 | 70,394 | 83,784 |
| Marketable Securities | 30,577 | 44,467 | 51,081 | 45,973 | 33,555 |
| Receivables | 13,120 | 11,670 | 11,080 | 10,522 | 12,105 |
| Inventories | 16,915 | 16,959 | 16,980 | 17,228 | 16,743 |
| TOTAL | $136,248 | $140,929 | $146,159 | $147,936 | $150,422 |
| Non-Current Assets | |||||
| PPE Net | 2,907 | 2,983 | 2,830 | 4,218 | 4,028 |
| Investments And Advances | 1,681 | 2,266 | 2,300 | 6,815 | 16,970 |
| Intangibles | 2,333 | 2,333 | 2,333 | 2,333 | 2,364 |
| Other Non-Current Assets | 19,681 | 18,890 | 19,005 | 3,282 | 3,997 |
| TOTAL | $26,602 | $26,472 | $26,468 | $16,648 | $27,359 |
| Total Assets | $162,850 | $167,401 | $172,627 | $164,584 | $177,781 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 99 | 93 | 5,231 | 2,155 |
| Accounts payable and accrued liabilities | 3,827 | 4,576 | 3,181 | 3,125 | 1,497 |
| Accrued Expenses | 16,472 | 12,779 | 11,783 | 10,071 | 16,234 |
| TOTAL | $24,437 | $18,300 | $16,301 | $21,294 | $23,157 |
| Non-Current Liabilities | |||||
| Long Term Debt | 34,002 | 37,137 | 37,110 | 32,002 | 35,089 |
| Deferred Revenues | 135 | 109 | 107 | 110 | 104 |
| Other Non-Current Liabilities | 18,515 | 17,910 | 17,914 | 650 | 1,106 |
| TOTAL | $52,604 | $55,176 | $55,142 | $32,792 | $36,309 |
| Total Liabilities | $77,041 | $73,476 | $71,443 | $54,086 | $59,466 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 39,796 | 39,488 | 39,153 | 38,816 | 38,537 |
| Common Shares | 40 | 39 | 39 | 39 | 39 |
| Retained earnings | -467,555 | -454,380 | -440,236 | -424,910 | -411,161 |
| Other shareholders' equity | 2,113 | 2,534 | 1,973 | 1,963 | 2,640 |
| TOTAL | $85,809 | $93,925 | $101,184 | $110,498 | $118,315 |
| Total Liabilities And Equity | $162,850 | $167,401 | $172,627 | $164,584 | $177,781 |